内皮质对共价抗红素-氨酸复合物的抗凝活性的影响
Helen M Atkinson1,2, Ivan Stevic3, Leslie R Berry1,2
1Thrombosis and Atherosclerosis Research Institute, McMaster University, Hamilton, ON, Canada.
一种新型的共价抗素-氨酸复合物 (ATH) 显示出强大的抗凝效应. 内皮没有改变ATH.
科学领域:
- 生物化学 生物化学
- 血液学 血液学 血液学
- 药理学 药理学是指药理学的学科.
背景情况:
- 抗凝固疗法对于管理血栓性疾病至关重要.
- 共性抗素-氨酸复合物 (ATH) 证明了体内疗效的增强.
- 之前的体外研究缺乏内皮细胞的存在,内皮细胞是血液静止的一个关键调节器.
研究的目的:
- 研究内皮质对ATH的体外抗凝性质的影响.
- 为了比较内皮对ATH的影响与非共价抗素 (AT) +未分离的肝素 (H).
主要方法:
- 酶抑制测定测量速度常数.
- 纤维素形成测试. 纤维素形成测试.
- 血凝块生成试验. 血凝块生成试验.
- 用和没有内皮细胞进行的实验.
主要成果:
- 与AT+H相比,ATH表现出更快的血栓 (IIa) 和XA因子 (Xa) 的直接抑制率.
- ATH显示加强了IIa诱导的纤维素形成的抑制,而不是AT+H.
- 内皮减少了ATH和AT+H的IIa抑制率和凝血时间,没有差异性影响.
结论:
- 与AT+H相比,内皮的存在不会对ATH的体外抗凝活性产生差异性影响.
- 在内皮质的存在下,ATH保持其抗凝性质.
- ATH代表了未来临床抗凝剂应用的有希望的候选者.
更多相关视频
07:08Assessment of the Anticoagulant and Anti-inflammatory Properties of Endothelial Cells Using 3D Cell Culture and Non-anticoagulated Whole Blood
Published on: September 5, 2017
09:41Hemocompatibility Testing of Blood-Contacting Implants in a Flow Loop Model Mimicking Human Blood Flow
Published on: March 5, 2020
相关概念视频
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Venous Thrombosis III: Interprofessional Care
Extrinsic and Intrinsic Pathways of Hemostasis
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
Venous Thrombosis I: Introduction
Therapeutic Index
